Skip to main content
. 2018 Oct 23;13(10):e0205827. doi: 10.1371/journal.pone.0205827

Fig 3. Probabilistic sensitivity analysis (PSA) results.

Fig 3

(A) Cost-Effectiveness Acceptability Curves Comparing the Cost-effectiveness of Crizotinib Treatment with the ALK Rearrangement Testing (NGS and multiplex PCR) Versus Standard Chemotherapy, with PAP; (B) Scatter Plot of Monte Carlo Probabilistic Sensitivity Analysis, NGS vs. Control Strategy, with Patient Assistance Program (PAP); (C) Scatter Plot of Monte Carlo Probabilistic Sensitivity Analysis, Multiplex PCR vs. Control Strategy, with Patient Assistance Program (PAP). Blue line indicates NGS and yellow one is multiplex PCR, ALK: anaplastic lymphoma kinase; NGS: next-generation sequencing; PAP: patient assistance program; QALY: quality-adjusted life-year; PCR: polymerase chain reaction.